Monosymptomatic unilateral optic neuritis
Abstract
Monosymptomatic unilateral optic neuritis is a common first manifestation of multiple sclerosis. Abnormal T cell responses to myelin components including myelin basic protein (MBP), proteolipid protein (PLP), and myelinassociated glycoprotein (MAG) have been implicated in the pathogenesis of multiple sclerosis. Antigen-reactive T helper type 1 (Thl)-like cells that responded by interferon y (IFN-y) secretion on antigen stimulation in vitro were counted. Untreated patients with optic neuritis and multiple sclerosis had similarly raised levels of T cells recognising MBP, PLP, and MAG in peripheral blood. Such T cells were strongly enriched in CSF. None of these myelin antigens functioned as iunodominant T cell antigen characteristic for optic neuritis or multiple sclerosis. The autoimmune T cell repertoire was not more restricted in optic neuritis (as an example of early multiple sclerosis). The autoreactive T cell repertoires differed in blood compared with CSF in individual patients with optic neuritis and multiple sclerosis. No relations were found between specificity or quantity of autoreactive T cells in blood or CSF, and clinical variables of optic neuritis or multiple sclerosis, or occurrence of oligoclonal IgG bands in CSF. The role of raised MBP, PLP, and MAG reactive Thl-like cells found in optic neuritis and multiple sclerosis remains unexplained. (MAG) , and myelin oligodendrocyte glycoprotein (MOG).27 These B cell responses comprise mainly the IgG isotype and can therefore be assumed to depend on T cell help. The finding that experimental allergic encephalomyelitis-which in its chronic form mimics multiple sclerosis both clinically and pathologically-is characterised by high concentrations of MBP reactive T cells and can be transferred with MBP specific T cells to naive recipients,8 has led to renewed efforts to investigate T cell specificities to myelin proteins in patients with multiple sclerosis.
The traditional ways to assess T cell sensitisation include measurements of 3H-thymidine incorporation as a reflection of antigen-induced T cell proliferation, and limiting dilution assays. Such studies have given variable results, although most of them concluded that a low percentage of patients with multiple sclerosis showed evidence of T cell sensitisation to MBP and PLP, and to MBP and PLP peptides, as did a somewhat lower percentage of control subjects.9 These techniques may, however, not be sensitive enough to detect the low frequencies of memory T cells that occur in human diseases with possible autoimmune background, nor are they useful to detect antigen reactive T cells among the low numbers of CSF cells usually available. A different approach that is based on counting cells that secrete an effector molecule in the form of interferon y (IFN-y) after in vitro stimulation with antigen, allows the definition of the T cell repertoire for specificity, quantity, and functional differentiation as far as the CD4 + T helper cell subtype 1 (Thl) related effector molecule IFN-y is concerned. After phagocytosis of myelin protein antigen by macrophages and processing, sequences comprising [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] amino acids join congruent major histocompatibility complex (MHC) class II molecules and are presented on the cell surface together with these molecules to T cells which recognise the antigen-MHC unit via the T cell receptor, thereby inducing the production and secretion of effector molecules including increased concentrations of Th 1-like cells secreting IFN-y on recognition of MBP, PLP, MAG, and MOG, and different MBP peptides, without immunodominance for any of the myelin protein antigens or peptides hitherto examined.6 11-14 When applied to CSF cells, it was shown that patients with multiple sclerosis had a strong accumulation of T cells with these autoreactivities in the CSF compartment.
Whether T cells in individual patients with multiple sclerosis respond to more than one myelin protein antigen in parallel has not been studied. Furthermore, it is not known whether a more restricted autoimmune T cell response occurs in early compared to late phases of multiple sclerosis. One rather common clinical manifestation that often represents the first clinical sign of multiple sclerosis is monosymptomatic unilateral optic neuritis. About half of the patients with a first attack of optic neuritis later develop multiple sclerosis. Here we report the results from studies of the T cell responses to MBP, PLP, and MAG in blood and CSF from patients with multiple sclerosis, optic neuritis, and other neurological diseases.
Patients and methods

PATIENTS
Optic neuritis Thirty-two patients (26 women) were included. Their mean age was 36 years. The interval between first symptoms of optic neuritis and present study was five days to three years (median 34 days). To be included, the patients must not have had any previous history of neurological disturbances that could in any way be related to multiple sclerosis, although recurrent 17 Purity of MBP was checked by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), which showed a single band migrating at about 22 kDa. PLP was isolated from bovine brain.'8 Purity was assessed by SDS-PAGE. It was free from any contamination with MBP as checked by western blotting. MAG was prepared by the lithium diiodosalisylate phenol method'9 from bovine brain myelin. Purity was checked by SDS-PAGE which revealed a single band migrating at 100 kDa, and by western blotting using serum from a patient with monoclonal anti-MAG IgM which bound to the single 100 kDa band.
PREPARATION OF MONONUCLEAR CELLS FROM CSF AND BLOOD
A 20-mi volume of CSF was collected into siliconised glass tubes and centrifuged for 10 minutes at 200 g. The cells in the pellet were resuspended in Iscove's modification of Dulbecco's medium supplemented with 2 mM L-glutamine, 1% (v/v) minimal essential medium (all from Flow laboratories, Irvine, UK), 10% (v/v) fetal calf serum (Gibco, Paisley, UK), and antibiotics, centrifuged and rediluted to 4-10 x 104 cells/ml. Venous blood was collected into heparinised glass tubes and diluted with the same volume of medium. Mononuclear cells were obtained by density gradient centrifugation on Lymphoprep (Nyegaard, Oslo, Norway). The cells from the interphase were carefully collected and washed three times with medium and antibiotics, resuspended in medium, counted, and adjusted to 106 cells/ml.
ENUMERATION OF MYELIN PROTEIN REACTIVE T CELLS
Antigen specific T cells in CSF and blood were counted in an IFN-y immunospot assay as previously described." Briefly, 200 ,ul aliquots containing 2 x 105 blood mononuclear cells in duplicate or 100 ul aliquots containing 4-10 x 105 CSF cells (rarely in duplicate because of low numbers of CSF cells available) were added to individual wells of microtitre plates with 96 wells and nitrocellulose bottoms, which were coated with a mouse monoclonal anti-human IFN-y antibody (7-B6-5 plates were incubated and washed, and biotinylated anti-rabbit IgG (Vector Laboratories, Burlingame, CA, USA) was added, followed by avidin-biotin peroxidase complex (ABC Vectastain Elite Kit; Vector) and peroxidase staining. The red-brown spots that correponded to the cells that had secreted IFN-y were counted with a dissection microscope under x 25 magnification. No spots appeared when the rabbit polyclonal anti-human IFN-y antiserum was substituted by a mouse anti-rat IFN-y antibody or an irrelevant mouse monoclonal antibody, or when the rabbit polyclonal antibody was omitted. Results were expressed as numbers of spots/ 105 mononuclear cells after subtraction of values in the background control cultures with no antigen added. Because in some patients the numbers of IFN-y secreting cells were higher in the control cultures than in cultures exposed to antigen, subtraction in these instances resulted in negative values. A patient was considered a responder to a given antigen if the value after subtraction was above 0. All countings were performed without knowledge of the clinical diagnosis or the antigen employed. The variation of quadruplicate cultures in preliminary experiments was regularly less than 10%. The spots detected in the assay are the results of MHC restricted antigen presentation to T cells and reflect individual antigen reactive T cells secreting IFN-y. 13 21 
STATISTICS
The Mann-Whitney test was used.
Results
MYELIN PROTEIN REACTIVE T CELLS IN BLOOD AND CSF IN OPTIC NEURITIS
Most of the patients with optic neuritis had MBP, PLP, and MAG reactive T cells in peripheral blood (fig 1; table 1 Any of the three myelin proteins functioned as an immune dominant T cell antigen in individual patients with optic neuritis, multiple sclerosis, and other necrological diseases (table 3) . The results did not disclose any multiple sclerosis or optic neuritis specific T cell antigen among MBP, PLP, and MAG. To study the predominant T cell response in individual patients and compare mononuclear cells in blood v CSF of the same patient, T cell responses to MBP, PLP, and MAG were examined in parallel in blood and CSF from 10 patients with optic neuritis, six with multiple sclerosis and six with OND (table 4) . One patient with optic neuritis and two with other neurological diseases had no responding T cells either in blood or in CSF. Only two of the 10 patients with optic neuritis (Nos 1 and 7) had a dominant T cell response to the same antigen (MBP) in both blood and CSF whereas, in the remaining seven patients with optic neuritis, the dominant T cell antigen varied in the individual patient when blood and CSF data were compared. Two patients with optic neuritis (Nos 5 and 8) had MBP reactive T cells in CSF only. Among the six patients with multiple sclerosis, synchronous immune dominance in blood and CSF to MAG was found in two patients (Nos 1 and 5). The remaining four patients with multiple sclerosis and the four with other neurological diseases showed different patterns of T cell responses to MBP, PLP, and MAG when results from the simultaneous studies on mononuclear cells in blood and CSF were compared. Thus the autonomy of the intrathecal T cell response was not only reflected by the much higher numbers of myelin protein reactive T cells in CSF compared with blood ( The 32 patients with optic neuritis were divided into two groups of equal size with regard to short v long interval between onset of clinical signs and symptoms of optic neuritis and the time of CSF and blood sampling. Numbers of T cells responding to each of the three myelin protein antigens, or the sum of MBP + PLP + MAG reactive T cells, did not differ significantly between groups with short or long intervals.
The patients with multiple sclerosis were divided into those with clinical exacerbation v remission or chronic progressive multiple sclerosis, duration of disease <8 years compared with >8 years, no or slight v moderate or severe disability, and a more v less benign course based on the outcome of the malignancy index (see under PATIENTS). No statistically significant differences between numbers of T cells in blood or CSF responding to any of the three myelin proteins, or the sum of MBP + PLP + MAG reactive T cells could be found in any of these clinical subgroups. No correlation was found between the clinical variables studied and levels of myelin protein responding T cells.
Discussion
Patients with optic neuritis had autoimmune T cells in their CSF recognising the three major myelin proteins MBP, PLP, and MAG-that is, myelin components that could constitute targets for a putative autoimmune attack in multiple sclerosis. The proportions of these autoimmune T cells in CSF were similar in optic neuritis and multiple sclerosis, suggesting that there was no restriction of the T cell repertoire in early multiple sclerosis as reflected by optic neuritis. Also in peripheral blood, increases of T cells with these specificities were detected both in patients with optic neuritis and multiple sclerosis, but the relative numbers of T cells with these specificities were much lower than in CSF. In the search for a "multiple sclerosis antigen", we have for the first time also defined the T cell repertoire in individual patients to different myelin proteins (MBP, PLP, and MAG) in parallel. No immunodominant response to any of these myelin protein antigens was found in either optic neuritis or multiple sclerosis. Instead, T cells from individual patients responded predominantly to one or the other of these myelin proteins. Different response patterns were found in CSF compared with blood in individual patients as further evidence of an autonomous autoimmune T cell response in the CSF compartment.
It has previously been documented that the presently used IFN-y immunospot assay is a useful tool to examine the T cell repertoire regarding specificity and quantity.'1-'42' IFN-y has many functions, including induction of MHC class II antigens on targets of the autoaggressive attack in organ-specific autoimmune diseases-for example, pancreatic /3 cells in nude mice,22 thyroid epithelial cells in obese strain chickens,2' and astrocytes in mouse and rat strains susceptible for the induction of experimental allergic encephalitis. 24 It has also been shown that IFN-y, when given systemically, worsens multiple sclerosis. 25 The present study clearly showed that multiple sclerosis as well as optic neuritis is accompanied by a strong enrichment in the CSF of Thl-like cells secreting IFN-y on recognition of MBP, PLP, and MAG. Raised concentrations of MBP occur regularly in CSF from patients with multiple sclerosis.
The continuous process of IFN-y secretion, as envisaged by the inflammatory lesions affecting the brain in multiple sclerosis, could have an important influence on the course of the disease.
We subtracted the numbers of IFN-y secreting cells obtained in background control cultures with no antigen added from numbers in cultures exposed to antigen (MBP, PLP, or MAG). In some patients the numbers of IFN-y spots were higher in the control cultures without antigen than in cultures exposed to antigen, thereby explaining the negative values for numbers of myelin antigen specific T cells sometimes found ( 
